Kcs Wealth Advisory Amgen Inc Transaction History

Kcs Wealth Advisory

$224 Million
Q3 2023

A detailed history of Kcs Wealth Advisory transactions in Amgen Inc stock. As of the latest transaction made, Kcs Wealth Advisory holds 1,016 shares of AMGN stock, worth $268,721. This represents 0.12% of its overall portfolio holdings.

Number of Shares

1,016

Previous 1,780 42.92%

Holding current value

$268,721

Previous $395,000 30.89%

% of portfolio

0.12%

Previous 0.14%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$218.65 - $271.46 $167,048 - $207,395	-764 Reduced 42.92%	1,016 $273,000
Q2 2023 Jul 17, 2023	BUY	$214.27 - $253.37 $2,999 - $3,547	14 Added 0.79%	1,780 $395,000
Q1 2023 Apr 17, 2023	SELL	$225.79 - $275.2 $1,580 - $1,926	-7 Reduced 0.39%	1,766 $426,000
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $1,374 - $1,746	-6 Reduced 0.34%	1,773 $465,000
Q3 2022 Oct 21, 2022	BUY	$224.46 - $253.15 $2,244 - $2,531	10 Added 0.57%	1,779 $401,000
Q1 2022 Apr 13, 2022	BUY	$219.27 - $242.57 $2,850 - $3,153	13 Added 0.74%	1,769 $428,000
Q4 2021 Jan 26, 2022	SELL	$198.88 - $227.6 $1,591 - $1,820	-8 Reduced 0.45%	1,756 $395,000
Q2 2021 Jul 27, 2021	SELL	$233.58 - $259.14 $233 - $259	-1 Reduced 0.06%	1,764 $430,000
Q1 2021 Apr 19, 2021	BUY	$221.91 - $258.6 $81,219 - $94,647	366 Added 26.16%	1,765 $439,000
Q4 2020 Jan 28, 2021	BUY	$216.38 - $257.67 $432 - $515	2 Added 0.14%	1,399 $322,000
Q3 2020 Oct 27, 2020	BUY	$234.65 - $260.95 $469 - $521	2 Added 0.14%	1,397 $355,000
Q2 2020 Jul 16, 2020	BUY	$197.81 - $242.74 $6,923 - $8,495	35 Added 2.57%	1,395 $329,000
Q1 2020 Apr 28, 2020	SELL	$182.24 - $241.7 $182 - $241	-1 Reduced 0.07%	1,360 $276,000
Q4 2019 Jan 15, 2020	BUY	$189.21 - $243.2 $4,162 - $5,350	22 Added 1.64%	1,361 $328,000
Q3 2019 Oct 29, 2019	BUY	$174.11 - $208.62 $4,700 - $5,632	27 Added 2.06%	1,339 $259,000
Q2 2019 Jul 29, 2019	SELL	$166.7 - $195.41 $4,000 - $4,689	-24 Reduced 1.8%	1,312 $242,000
Q1 2019 Apr 29, 2019	BUY	$180.87 - $203.88 $3,255 - $3,669	18 Added 1.37%	1,336 $254,000
Q4 2018 Jan 17, 2019	BUY	$178.4 - $208.25 $1,962 - $2,290	11 Added 0.84%	1,318 $257,000
Q3 2018 Nov 06, 2018	SELL	$185.29 - $208.89 $31,684 - $35,720	-171 Reduced 11.57%	1,307 $271,000
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $5,313 - $5,968	-32 Reduced 2.12%	1,478 $273,000
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $255,839 - $298,980	1,510 New	1,510 $257,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kcs Wealth Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Kcs Wealth Advisory with notifications on news.

Account

Kcs Wealth Advisory Amgen Inc Transaction History